Female stem cells are superior to males in preserving myocardial function following endotoxemia

Mariuxi C. Manukyan, Brent R. Weil, Yue Wang, Aaron M. Abarbanell, Jeremy L. Herrmann, Jeffrey A. Poynter, Benjamin D. Brewster, Daniel R. Meldrum

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) may offer therapeutic benefit in the setting of sepsis and endotoxemia. Previous studies suggest that MSCs from female donors may possess better protective capabilities than their male counterparts. The present study examined whether female MSCs may offer a greater protective advantage in the setting of endotoxemic cardiac dysfunction compared with male MSCs. Adult male Sprague-Dawley rats were injected intraperitoneally with LPS and then treated with intraperitoneal injections of either saline, female MSCs, or male MSCs. Hearts and serum were then collected for analysis of myocardial function, myocardial protein, and myocardial and serum cytokines. Compared with male MSC or vehicle-treated animals, female MSC treatment resulted in greater preservation of myocardial function (P < 0.001). Serum and myocardial levels of all measured cytokines were comparable between rats given MSCs from male or female donors but substantially improved over rats given vehicle (P < 0.05). Reduced myocardial inflammation correlated with reduced levels of phosphorylated p38 MAPK expression in the myocardium of animals injected with MSCs of either sex (P < 0.05). The Bcl-xL/Bax ratio was increased to a greater extent following treatment with female MSCs vs. male MSCs (P < 0.05). Intraperitoneal administration of MSCs is effective in limiting myocardial inflammation and dysfunction in the rat endotoxemia model. Compared with treatment with their male counterparts, MSC treatment from female donors is associated with greater cardiac protection against acute endotoxemic injury.

Original languageEnglish
Pages (from-to)1506-1514
Number of pages9
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume300
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Endotoxemia
Mesenchymal Stromal Cells
Stem Cells
Cytokines
Inflammation
Therapeutics
p38 Mitogen-Activated Protein Kinases
Intraperitoneal Injections
Serum
Sprague Dawley Rats
Blood Proteins

Keywords

  • Apoptosis
  • Mesenchymal stem cell
  • Myocardial injury
  • Sepsis
  • Sex

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Female stem cells are superior to males in preserving myocardial function following endotoxemia. / Manukyan, Mariuxi C.; Weil, Brent R.; Wang, Yue; Abarbanell, Aaron M.; Herrmann, Jeremy L.; Poynter, Jeffrey A.; Brewster, Benjamin D.; Meldrum, Daniel R.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 300, No. 6, 06.2011, p. 1506-1514.

Research output: Contribution to journalArticle

Manukyan, Mariuxi C. ; Weil, Brent R. ; Wang, Yue ; Abarbanell, Aaron M. ; Herrmann, Jeremy L. ; Poynter, Jeffrey A. ; Brewster, Benjamin D. ; Meldrum, Daniel R. / Female stem cells are superior to males in preserving myocardial function following endotoxemia. In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 2011 ; Vol. 300, No. 6. pp. 1506-1514.
@article{21636f81254344528309dbef7c58088a,
title = "Female stem cells are superior to males in preserving myocardial function following endotoxemia",
abstract = "Mesenchymal stem cells (MSCs) may offer therapeutic benefit in the setting of sepsis and endotoxemia. Previous studies suggest that MSCs from female donors may possess better protective capabilities than their male counterparts. The present study examined whether female MSCs may offer a greater protective advantage in the setting of endotoxemic cardiac dysfunction compared with male MSCs. Adult male Sprague-Dawley rats were injected intraperitoneally with LPS and then treated with intraperitoneal injections of either saline, female MSCs, or male MSCs. Hearts and serum were then collected for analysis of myocardial function, myocardial protein, and myocardial and serum cytokines. Compared with male MSC or vehicle-treated animals, female MSC treatment resulted in greater preservation of myocardial function (P < 0.001). Serum and myocardial levels of all measured cytokines were comparable between rats given MSCs from male or female donors but substantially improved over rats given vehicle (P < 0.05). Reduced myocardial inflammation correlated with reduced levels of phosphorylated p38 MAPK expression in the myocardium of animals injected with MSCs of either sex (P < 0.05). The Bcl-xL/Bax ratio was increased to a greater extent following treatment with female MSCs vs. male MSCs (P < 0.05). Intraperitoneal administration of MSCs is effective in limiting myocardial inflammation and dysfunction in the rat endotoxemia model. Compared with treatment with their male counterparts, MSC treatment from female donors is associated with greater cardiac protection against acute endotoxemic injury.",
keywords = "Apoptosis, Mesenchymal stem cell, Myocardial injury, Sepsis, Sex",
author = "Manukyan, {Mariuxi C.} and Weil, {Brent R.} and Yue Wang and Abarbanell, {Aaron M.} and Herrmann, {Jeremy L.} and Poynter, {Jeffrey A.} and Brewster, {Benjamin D.} and Meldrum, {Daniel R.}",
year = "2011",
month = "6",
doi = "10.1152/ajpregu.00518.2010",
language = "English",
volume = "300",
pages = "1506--1514",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Female stem cells are superior to males in preserving myocardial function following endotoxemia

AU - Manukyan, Mariuxi C.

AU - Weil, Brent R.

AU - Wang, Yue

AU - Abarbanell, Aaron M.

AU - Herrmann, Jeremy L.

AU - Poynter, Jeffrey A.

AU - Brewster, Benjamin D.

AU - Meldrum, Daniel R.

PY - 2011/6

Y1 - 2011/6

N2 - Mesenchymal stem cells (MSCs) may offer therapeutic benefit in the setting of sepsis and endotoxemia. Previous studies suggest that MSCs from female donors may possess better protective capabilities than their male counterparts. The present study examined whether female MSCs may offer a greater protective advantage in the setting of endotoxemic cardiac dysfunction compared with male MSCs. Adult male Sprague-Dawley rats were injected intraperitoneally with LPS and then treated with intraperitoneal injections of either saline, female MSCs, or male MSCs. Hearts and serum were then collected for analysis of myocardial function, myocardial protein, and myocardial and serum cytokines. Compared with male MSC or vehicle-treated animals, female MSC treatment resulted in greater preservation of myocardial function (P < 0.001). Serum and myocardial levels of all measured cytokines were comparable between rats given MSCs from male or female donors but substantially improved over rats given vehicle (P < 0.05). Reduced myocardial inflammation correlated with reduced levels of phosphorylated p38 MAPK expression in the myocardium of animals injected with MSCs of either sex (P < 0.05). The Bcl-xL/Bax ratio was increased to a greater extent following treatment with female MSCs vs. male MSCs (P < 0.05). Intraperitoneal administration of MSCs is effective in limiting myocardial inflammation and dysfunction in the rat endotoxemia model. Compared with treatment with their male counterparts, MSC treatment from female donors is associated with greater cardiac protection against acute endotoxemic injury.

AB - Mesenchymal stem cells (MSCs) may offer therapeutic benefit in the setting of sepsis and endotoxemia. Previous studies suggest that MSCs from female donors may possess better protective capabilities than their male counterparts. The present study examined whether female MSCs may offer a greater protective advantage in the setting of endotoxemic cardiac dysfunction compared with male MSCs. Adult male Sprague-Dawley rats were injected intraperitoneally with LPS and then treated with intraperitoneal injections of either saline, female MSCs, or male MSCs. Hearts and serum were then collected for analysis of myocardial function, myocardial protein, and myocardial and serum cytokines. Compared with male MSC or vehicle-treated animals, female MSC treatment resulted in greater preservation of myocardial function (P < 0.001). Serum and myocardial levels of all measured cytokines were comparable between rats given MSCs from male or female donors but substantially improved over rats given vehicle (P < 0.05). Reduced myocardial inflammation correlated with reduced levels of phosphorylated p38 MAPK expression in the myocardium of animals injected with MSCs of either sex (P < 0.05). The Bcl-xL/Bax ratio was increased to a greater extent following treatment with female MSCs vs. male MSCs (P < 0.05). Intraperitoneal administration of MSCs is effective in limiting myocardial inflammation and dysfunction in the rat endotoxemia model. Compared with treatment with their male counterparts, MSC treatment from female donors is associated with greater cardiac protection against acute endotoxemic injury.

KW - Apoptosis

KW - Mesenchymal stem cell

KW - Myocardial injury

KW - Sepsis

KW - Sex

UR - http://www.scopus.com/inward/record.url?scp=79958862538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958862538&partnerID=8YFLogxK

U2 - 10.1152/ajpregu.00518.2010

DO - 10.1152/ajpregu.00518.2010

M3 - Article

VL - 300

SP - 1506

EP - 1514

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 6

ER -